Pradyun Chakravarty 
Dealstreet

Legacy Law Offices acts on Sheel Biotech IPO

The IPO comprised a fresh offer of 54,00,000 shares, aggregating to ₹34.1 crore.

Bar & Bench

Sheel Biotech Limited has made an initial public offering comprising a fresh offer of 54,00,000 shares, aggregating to ₹34.1 crore.

Legacy Law Offices advised Sheel Biotech on this IPO.

The transaction was led by Pradyun Chakravarty (Associate Partner), with support from Nandish Munjal (Senior Associate) and Sayed Anas (Associate).

Sheel Biotech

Sheel Biotech is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. The Company manufactures and maintains greenhouses, offers services to farmers, and provides training through Farmer-Producer Organisations (FPOs). Additionally, the Company also delivers green landscaping services to both the government and private sectors.

The IPO received a robust response and was oversubscribed by 15.97 times.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Bihar SIR case in Supreme Court: LIVE UPDATES

Why can't law colleges have reservation for transgender persons? Kerala High Court asks BCI

Supreme Court declines blanket order in Bihar SIR; asks those excluded from voters list to file appeals

Must not be forgotten: Supreme Court Justice Ujjal Bhuyan on lawyer's attempt to attack CJI BR Gavai

Bombay High Court restrains cab operators from using Reliance's 'Jio' trademark

SCROLL FOR NEXT